Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 992

1.

Remote Welfare Monitoring of Rodents Using Thermal Imaging.

Pereira CB, Kunczik J, Zieglowski L, Tolba R, Abdelrahman A, Zechner D, Vollmar B, Janssen H, Thum T, Czaplik M.

Sensors (Basel). 2018 Oct 28;18(11). pii: E3653. doi: 10.3390/s18113653.

2.

Regulatory Aspects of the Development of Drugs for Metabolic Bone Diseases - FDA and EMA Perspective.

Kehoe T, Blind E, Janssen H.

Br J Clin Pharmacol. 2018 Oct 18. doi: 10.1111/bcp.13791. [Epub ahead of print] Review.

PMID:
30335197
3.

Mechanisms of integrin αVβ5 clustering in flat clathrin lattices.

Zuidema A, Wang W, Kreft M, Te Molder L, Hoekman L, Bleijerveld OB, Nahidiazar L, Janssen H, Sonnenberg A.

J Cell Sci. 2018 Nov 5;131(21). pii: jcs221317. doi: 10.1242/jcs.221317.

PMID:
30301780
4.

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

van Tilborg M, Al Marzooqi SH, Wong WWL, Maan R, Vermehren J, Maasoumy B, Mazzulli T, Bolotin S, Garber G, Guerra F, Flud CR, Kowgier M, Janssen HL, de Knegt RJ, Pawlotsky JM, Cloherty GA, Duarte-Rojo A, Sarrazin C, Wedemeyer H, Feld JJ.

Lancet Gastroenterol Hepatol. 2018 Sep 28. pii: S2468-1253(18)30271-1. doi: 10.1016/S2468-1253(18)30271-1. [Epub ahead of print]

PMID:
30274834
5.

Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes.

Younossi ZM, Stepanova M, Younossi I, Pan CQ, Janssen HLA, Papatheodoridis G, Nader F.

Clin Gastroenterol Hepatol. 2018 Sep 27. pii: S1542-3565(18)31073-5. doi: 10.1016/j.cgh.2018.09.041. [Epub ahead of print] No abstract available.

PMID:
30268565
6.

Breaking up sitting time after stroke (BUST-stroke).

English C, Janssen H, Crowfoot G, Callister R, Dunn A, Mackie P, Oldmeadow C, Ong LK, Palazzi K, Patterson AJ, Spratt NJ, Walker FR, Bernhardt J, Dunstan DW.

Int J Stroke. 2018 Sep 18:1747493018801222. doi: 10.1177/1747493018801222. [Epub ahead of print]

PMID:
30226448
7.

Frequent, short bouts of light-intensity exercises while standing decreases systolic blood pressure: Breaking Up Sitting Time after Stroke (BUST-Stroke) trial.

English C, Janssen H, Crowfoot G, Bourne J, Callister R, Dunn A, Oldmeadow C, Ong LK, Palazzi K, Patterson A, Spratt NJ, Walker FR, Dunstan DW, Bernhardt J.

Int J Stroke. 2018 Sep 17:1747493018798535. doi: 10.1177/1747493018798535. [Epub ahead of print]

PMID:
30223728
8.

Correction: Modelling of thermal transport through a nanocellular polymer foam: toward the generation of a new superinsulating material.

Wang G, Wang C, Zhao J, Wang G, Park CB, Zhao G, Van De Walle W, Janssen H.

Nanoscale. 2018 Nov 8;10(43):20469-20473. doi: 10.1039/c8nr90192a.

PMID:
30209498
9.

Elevated Presepsin Is Associated With Perioperative Major Adverse Cardiovascular and Cerebrovascular Complications in Elevated-Risk Patients Undergoing Noncardiac Surgery: The Leukocytes and Cardiovascular Perioperative Events Study.

Handke J, Scholz AS, Gillmann HJ, Janssen H, Dehne S, Arens C, Kummer L, Uhle F, Weigand MA, Motsch J, Larmann J.

Anesth Analg. 2018 Sep 5. doi: 10.1213/ANE.0000000000003738. [Epub ahead of print]

PMID:
30198925
10.
11.

Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up.

van Campenhout MJH, Brouwer WP, Xie Q, Guo S, Chi H, Qi X, Tabak F, Streinu-Cercel A, Wang JY, Zhang NP, Idilman R, Reesink HW, Diculescu M, Simon K, Akdogan M, Mazur W, de Knegt RJ, Verhey E, Hansen BE, Janssen HLA; ARES Study Group.

J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.12997. [Epub ahead of print]

PMID:
30187612
12.

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.

Muir AJ, Levy C, Janssen HLA, Montano-Loza AJ, Shiffman ML, Caldwell S, Luketic V, Ding D, Jia C, McColgan BJ, McHutchison JG, Subramanian GM, Myers RP, Manns M, Chapman R, Afdhal NH, Goodman Z, Eksteen B, Bowlus CL; GS-US-321-0102 Investigators.

Hepatology. 2018 Aug 28. doi: 10.1002/hep.30237. [Epub ahead of print]

PMID:
30153359
13.

Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome.

Kindts I, Laenen A, Christiaens M, Janssen H, Van Limbergen E, Weltens C.

Strahlenther Onkol. 2018 Aug 23. doi: 10.1007/s00066-018-1346-7. [Epub ahead of print]

PMID:
30140943
14.

Heterogeneity of Network Structures and Water Dynamics in κ-Carrageenan Gels Probed by Nanoparticle Diffusometry.

de Kort DW, Schuster E, Hoeben FJM, Barnes R, Emondts M, Janssen HM, Lorén N, Han S, Van As H, van Duynhoven JPM.

Langmuir. 2018 Sep 18;34(37):11110-11120. doi: 10.1021/acs.langmuir.8b01052. Epub 2018 Sep 6.

15.

Impact of Comorbidities and Smoking on the Outcome in Aneurysmal Subarachnoid Hemorrhage.

Hammer A, Steiner A, Ranaie G, Yakubov E, Erbguth F, Hammer CM, Killer-Oberpfalzer M, Steiner H, Janssen H.

Sci Rep. 2018 Aug 17;8(1):12335. doi: 10.1038/s41598-018-30878-9.

16.

Severe Positional Central Sleep Apnea in an Asymptomatic Adult With a PHOX2B Frameshift Mutation.

Janssen HCJP, Vulto-van Silfhout AT, Jongmans MCJ, van der Hout AH, Overeem S.

J Clin Sleep Med. 2018 Aug 15;14(8):1427-1430. doi: 10.5664/jcsm.7290.

PMID:
30092902
17.

Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study.

Alferink LJ, Kiefte-de Jong JC, Erler NS, Veldt BJ, Schoufour JD, de Knegt RJ, Ikram MA, Metselaar HJ, Janssen H, Franco OH, Darwish Murad S.

Gut. 2018 Jul 31. pii: gutjnl-2017-315940. doi: 10.1136/gutjnl-2017-315940. [Epub ahead of print]

PMID:
30064987
18.

Activity monitors for increasing physical activity in adult stroke survivors.

Lynch EA, Jones TM, Simpson DB, Fini NA, Kuys SS, Borschmann K, Kramer S, Johnson L, Callisaya ML, Mahendran N, Janssen H, English C; ACTIOnS Collaboration.

Cochrane Database Syst Rev. 2018 Jul 27;7:CD012543. doi: 10.1002/14651858.CD012543.pub2. Review.

PMID:
30051462
19.

The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.

Jhaveri KS, Hosseini-Nik H, Sadoughi N, Janssen H, Feld JJ, Fischer S, Menezes R, Cheung AC.

Eur Radiol. 2018 Jul 26. doi: 10.1007/s00330-018-5619-4. [Epub ahead of print]

PMID:
30051141
20.

microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.

Jiang XM, Yu XN, Liu TT, Zhu HR, Shi X, Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Huang XX, Dong L, Janssen HLA, Shen XZ, Zhu JM.

Biomed Pharmacother. 2018 Sep;105:1147-1154. doi: 10.1016/j.biopha.2018.06.097. Epub 2018 Jun 21.

PMID:
30021351
21.

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.

Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Franke K, Schornagel K, Verkuijlen P, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, van der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK.

Cell Rep. 2018 Jun 26;23(13):3946-3959.e6. doi: 10.1016/j.celrep.2018.05.082.

22.

Spermine oxidase is upregulated and promotes tumor growth in hepatocellular carcinoma.

Hu T, Sun D, Zhang J, Xue R, Janssen HLA, Tang W, Dong L.

Hepatol Res. 2018 Jun 20. doi: 10.1111/hepr.13206. [Epub ahead of print]

PMID:
29923661
23.

Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy.

Chi H, Li Z, Hansen BE, Yu T, Zhang X, Sun J, Hou J, Janssen HLA, Peng J.

Clin Gastroenterol Hepatol. 2018 Jun 11. pii: S1542-3565(18)30600-1. doi: 10.1016/j.cgh.2018.05.047. [Epub ahead of print]

PMID:
29902645
24.

Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.

Zhu HR, Huang RZ, Yu XN, Shi X, Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Dong L, Janssen HLA, Shen XZ, Zhu JM.

Tohoku J Exp Med. 2018 Jun;245(2):89-98. doi: 10.1620/tjem.245.89.

25.

Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells.

Schillemans M, Karampini E, van den Eshof BL, Gangaev A, Hofman M, van Breevoort D, Meems H, Janssen H, Mulder AA, Jost CR, Escher JC, Adam R, Carter T, Koster AJ, van den Biggelaar M, Voorberg J, Bierings R.

Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1549-1561. doi: 10.1161/ATVBAHA.117.310701. Epub 2018 Jun 7.

26.

Hepatitis B virus infection.

Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL.

Nat Rev Dis Primers. 2018 Jun 7;4:18035. doi: 10.1038/nrdp.2018.35. Review.

PMID:
29877316
27.

Closure of large bore 9 F arterial puncture sites with the AngioSeal STS device in acute stroke patients after intravenous recombinant tissue plasminogen activator (rt-PA).

Janssen H, Killer-Oberpfalzer M, Lange R.

J Neurointerv Surg. 2018 May 15. pii: neurintsurg-2018-013829. doi: 10.1136/neurintsurg-2018-013829. [Epub ahead of print]

PMID:
29764930
28.

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.

Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY; GS-US-320-0110; GS-US-320-0108 Investigators.

J Hepatol. 2018 Apr;68(4):672-681. doi: 10.1016/j.jhep.2017.11.039. Epub 2018 Jan 17.

PMID:
29756595
29.

Click-to-Release from trans-Cyclooctenes: Mechanistic Insights and Expansion of Scope from Established Carbamate to Remarkable Ether Cleavage.

Versteegen RM, Ten Hoeve W, Rossin R, de Geus MAR, Janssen HM, Robillard MS.

Angew Chem Int Ed Engl. 2018 Aug 13;57(33):10494-10499. doi: 10.1002/anie.201800402. Epub 2018 Jun 27.

PMID:
29746709
30.

Selective labeling for the identification and semi-quantification of lipid aldehydes in food products.

Hollebrands B, Varvaki E, Kaal S, Janssen HG.

Anal Bioanal Chem. 2018 May 10. doi: 10.1007/s00216-018-1101-z. [Epub ahead of print]

PMID:
29744561
31.

The European Medicines Agency's approval of new medicines for type 2 diabetes.

Blind E, Janssen H, Dunder K, de Graeff PA.

Diabetes Obes Metab. 2018 Sep;20(9):2059-2063. doi: 10.1111/dom.13349. Epub 2018 May 30. Review.

PMID:
29740935
32.

Employed family-based genetic discovery combining linkage analysis and exome sequencing to identify RCL1 as a novel candidate gene for depression, with independent replication in a population-based cohort.

Amin N, de Vrij FMS, Baghdadi M, Brouwer RWW, van Rooij JGJ, Jovanova O, Uitterlinden AG, Hofman A, Janssen HLA, Murad SD, Kraaij R, Stedehouder J, van den Hout MCGN, Kros JM, van IJcken WFJ, Tiemeier H, Kushner SA, van Duijn CM.

Mol Psychiatry. 2018 May;23(5):1093. doi: 10.1038/mp.2018.6. No abstract available.

PMID:
29731510
33.

Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice.

Rossin R, Versteegen RM, Wu J, Khasanov A, Wessels HJ, Steenbergen EJ, Ten Hoeve W, Janssen HM, van Onzen AHAM, Hudson PJ, Robillard MS.

Nat Commun. 2018 May 4;9(1):1484. doi: 10.1038/s41467-018-03880-y.

34.

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study.

Tadrous M, Brahmania M, Martins D, Knowles S, Janssen HLA, Mamdani MM, Juurlink DN, Gomes T.

J Manag Care Spec Pharm. 2018 May;24(5):464-468. doi: 10.18553/jmcp.2018.24.5.464.

35.

Younger age and language barriers are associated with nonadherence to clinical follow-up in hepatitis B treatment.

Chi H, Japhary A, de Man RA, de Knegt RJ, Janssen HLA, Hansen BE.

J Viral Hepat. 2018 Oct;25(10):1216-1219. doi: 10.1111/jvh.12920. Epub 2018 May 17. No abstract available.

PMID:
29679439
36.

Antimicrobial-Resistant Bacteria in Infected Wounds, Ghana, 20141.

Janssen H, Janssen I, Cooper P, Kainyah C, Pellio T, Quintel M, Monnheimer M, Groß U, Schulze MH.

Emerg Infect Dis. 2018 May;24(5):916-919. doi: 10.3201/eid2405.171506.

37.

MRI Visualization of Injectable Ureidopyrimidinone Hydrogelators by Supramolecular Contrast Agent Labeling.

Bakker MH, Tseng CCS, Keizer HM, Seevinck PR, Janssen HM, Van Slochteren FJ, Chamuleau SAJ, Dankers PYW.

Adv Healthc Mater. 2018 Jun;7(11):e1701139. doi: 10.1002/adhm.201701139. Epub 2018 Apr 15.

PMID:
29658175
38.

Synthesis and Self-Assembly of Bay-Substituted Perylene Diimide Gemini-Type Surfactants as Off-On Fluorescent Probes for Lipid Bilayers.

Schill J, van Dun S, Pouderoijen MJ, Janssen HM, Milroy LG, Schenning APHJ, Brunsveld L.

Chemistry. 2018 May 28;24(30):7734-7741. doi: 10.1002/chem.201801022. Epub 2018 May 3.

39.

European Multicenter Study for the Evaluation of a Dual-Layer Flow-Diverting Stent for Treatment of Wide-Neck Intracranial Aneurysms: The European Flow-Redirection Intraluminal Device Study.

Killer-Oberpfalzer M, Kocer N, Griessenauer CJ, Janssen H, Engelhorn T, Holtmannspötter M, Buhk JH, Finkenzeller T, Fesl G, Trenkler J, Reith W, Berlis A, Hausegger K, Augustin M, Islak C, Minnich B, Möhlenbruch M.

AJNR Am J Neuroradiol. 2018 May;39(5):841-847. doi: 10.3174/ajnr.A5592. Epub 2018 Mar 15.

PMID:
29545252
40.

Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment.

van Campenhout MJH, van Bömmel F, Pfefferkorn M, Fischer J, Deichsel D, Boonstra A, van Vuuren AJ, Berg T, Hansen BE, Janssen HLA.

Hepatology. 2018 Sep;68(3):839-847. doi: 10.1002/hep.29872. Epub 2018 Apr 27.

41.

Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported Outcomes.

Younossi ZM, Stepanova M, Janssen HLA, Agarwal K, Nguyen MH, Gane E, Tsai N, Younossi I, Racila A.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1641-1649.e6. doi: 10.1016/j.cgh.2018.02.037. Epub 2018 Mar 2.

PMID:
29505905
42.

Acute basilar thrombosis: Recanalization following intravenous thrombolysis is dependent on thrombus length.

Janssen H, Brückmann H, Killer M, Heck S, Buchholz G, Lutz J.

PLoS One. 2018 Feb 21;13(2):e0193051. doi: 10.1371/journal.pone.0193051. eCollection 2018.

43.

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.

Papatheodoridis GV, Sypsa V, Dalekos G, Yurdaydin C, van Boemmel F, Buti M, Goulis J, Calleja JL, Chi H, Manolakopoulos S, Loglio A, Siakavellas S, Gatselis N, Keskın O, Lehretz M, Savvidou S, de la Revilla J, Hansen BE, Kourikou A, Vlachogiannakos I, Galanis K, Idilman R, Colombo M, Esteban R, Janssen HLA, Berg T, Lampertico P.

J Hepatol. 2018 Jun;68(6):1129-1136. doi: 10.1016/j.jhep.2018.01.031. Epub 2018 Feb 8.

PMID:
29427727
44.

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B.

Wong D, Littlejohn M, Edwards R, Jackson K, Revill P, Gaggar A, Kitrinos K, Subramanian M, Marcellin P, Buti-Ferret M, Janssen H, Gane E, Locarnini S, Thompson A.

Liver Int. 2018 Oct;38(10):1760-1769. doi: 10.1111/liv.13716. Epub 2018 Mar 6.

PMID:
29427368
45.

Peroxiredoxin 1, restraining cell migration and invasion, is involved in hepatocellular carcinoma recurrence.

Fang Y, He J, Janssen HLA, Wu J, Dong L, Shen XZ.

J Dig Dis. 2018 Mar;19(3):155-169. doi: 10.1111/1751-2980.12580.

PMID:
29377617
46.

Correction: Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling.

Verweij FJ, Bebelman MP, Jimenez CR, Garcia-Vallejo JJ, Janssen H, Neefjes J, Knol JC, de Goeij-de Haas R, Piersma SR, Baglio SR, Verhage M, Middeldorp JM, Zomer A, van Rheenen J, Coppolino MG, Hurbain I, Raposo G, Smit MJ, Toonen RFG, van Niel G, Pegtel DM.

J Cell Biol. 2018 Mar 5;217(3):1157. doi: 10.1083/JCB.20170320601192018c. Epub 2018 Jan 23. No abstract available.

47.

Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling.

Verweij FJ, Bebelman MP, Jimenez CR, Garcia-Vallejo JJ, Janssen H, Neefjes J, Knol JC, de Goeij-de Haas R, Piersma SR, Baglio SR, Verhage M, Middeldorp JM, Zomer A, van Rheenen J, Coppolino MG, Hurbain I, Raposo G, Smit MJ, Toonen RFG, van Niel G, Pegtel DM.

J Cell Biol. 2018 Mar 5;217(3):1129-1142. doi: 10.1083/jcb.201703206. Epub 2018 Jan 16. Erratum in: J Cell Biol. 2018 Jan 23;:.

48.

Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.

Hectors SJ, Jacobs I, Lok J, Peters J, Bussink J, Hoeben FJ, Keizer HM, Janssen HM, Nicolay K, Schabel MC, Strijkers GJ.

Cancer Res. 2018 Mar 15;78(6):1561-1570. doi: 10.1158/0008-5472.CAN-17-2569. Epub 2018 Jan 9.

PMID:
29317433
49.

Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.

Harms MH, Lammers WJ, Thorburn D, Corpechot C, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Dalekos GN, Bruns T, Parés A, Mason AL, Verhelst X, Kowdley KV, Goet JC, Hirschfield GM, Hansen BE, van Buuren HR.

Am J Gastroenterol. 2018 Feb;113(2):254-264. doi: 10.1038/ajg.2017.440. Epub 2017 Dec 12.

PMID:
29231188
50.

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history.

Murillo Perez CF, Goet JC, Lammers WJ, Gulamhusein A, van Buuren HR, Ponsioen CY, Carbone M, Mason A, Corpechot C, Invernizzi P, Mayo MJ, Battezzati PM, Floreani A, Pares A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Thorburn D, Hirschfield G, LaRusso NF, Lindor KD, Zachou K, Poupon R, Trivedi PJ, Verhelst X, Janssen HLA, Hansen BE; GLOBAL PBC Study Group.

Hepatology. 2018 May;67(5):1920-1930. doi: 10.1002/hep.29717. Epub 2018 Apr 6.

PMID:
29220537

Supplemental Content

Loading ...
Support Center